Organigram (TSE:OGI) Shares Up 0.4% - Here's Why

Key Points

• Organigram Holdings Inc. shares increased by 0.4% to C$2.56, with a trading volume of 88,165 shares, a significant drop of 50% compared to its average session volume.
• The company has a market capital of C$342.74 million and a high P/E ratio of 213.33, indicating a potentially overvalued stock based on its current earnings.
• As a licensed producer of cannabis products, Organigram is focused on providing exceptional indoor-grown cannabis to both patients and adult recreational consumers.

Organigram Holdings Inc. (TSE:OGI - )'s stock price shot up 0.4% on Monday . The company traded as high as C$2.60 and last traded at C$2.56. 88,165 shares traded hands during trading, a decline of 50% from the average session volume of 175,602 shares. The stock had previously closed at C$2.55.

Organigram Trading Up 0.4%

The company has a debt-to-equity ratio of 3.07, a current ratio of 3.36 and a quick ratio of 2.62. The stock's 50-day moving average is C$2.42 and its two-hundred day moving average is C$2.00. The stock has a market cap of C$342.74 million, a P/E ratio of 213.33, a price-to-earnings-growth ratio of 0.42 and a beta of 2.19.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.